These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 25466839

  • 21. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
    Martinez C, Katholing A, Folkerts K, Cohen AT.
    J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
    [Abstract] [Full Text] [Related]

  • 22. Safety of anticoagulant treatment in cancer patients.
    Wilts IT, Bleker SM, Van Es N, Büller HR, Di Nisio M, Kamphuisen PW.
    Expert Opin Drug Saf; 2015 Aug; 14(8):1227-36. PubMed ID: 26059964
    [Abstract] [Full Text] [Related]

  • 23. Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.
    Carrier M, Le Gal G, Cho R, Tierney S, Rodger M, Lee AY.
    J Thromb Haemost; 2009 May; 7(5):760-5. PubMed ID: 19245418
    [Abstract] [Full Text] [Related]

  • 24. Venous thromboembolism in cancer patients.
    Deng A, Galanis T, Graham MG.
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE, King JH, Branch JM, Chow SL, Ferrer RE, Pak S, Togioka PY, White RH.
    Ann Pharmacother; 2005 Dec; 39(7-8):1182-7. PubMed ID: 15956232
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment.
    Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, del Toro J, Sahuquillo JC, Pedrajas JM, Huisman MV.
    J Thromb Haemost; 2013 Nov; 11(11):1968-76. PubMed ID: 24112123
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F.
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The treatment of venous thromboembolism in patients with cancer.
    Prandoni P.
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
    [Abstract] [Full Text] [Related]

  • 35. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II.
    Spirk D, Ugi J, Korte W, Husmann M, Hayoz D, Baldi T, Frauchiger B, Banyai M, Aujesky D, Baumgartner I, Kucher N.
    Thromb Haemost; 2011 Jun; 105(6):962-7. PubMed ID: 21475778
    [Abstract] [Full Text] [Related]

  • 36. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E, Feugère G, Sirois C, Weicker S, Ramos E.
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Menapace LA, McCrae KR, Khorana AA.
    Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.